Tech Company Financing Transactions
Oberland Biotech Funding Round
999 Family Office participated in a $3.2 million Seed capital raise for Oberland Biotech. The financing was announced on 5/1/2026.
Transaction Overview
Company Name
Announced On
5/1/2026
Transaction Type
Debt
Amount
$3,200,000
Round
Seed
Investors
999 Family Office (Raghun Kataria)
Proceeds Purpose
This new financing will enable Oberland Biotech to further accelerate its development across key strategic areas, including product development, international expansion, recruitment, and marketing and sales growth.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
Untere Roostmatt 8
Zoug, 6300
Swizerland
Zoug, 6300
Swizerland
Phone
Undisclosed
Website
Email Address
Overview
The mission of Oberland Biotech is to contribute to improving nutrition and well-being through innovative and responsible food solutions. The company is committed to developing and distributing high-quality products that meet the expectations of modern consumers in terms of health, food safety, and sustainability. By focusing on innovation, science, and quality, Oberland Biotech aims to build a business model capable of combining economic performance, scientific progress, and respect for the environment.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Phillip Jancer
Browse more venture capital transactions:
Prev: 5/1/2026: DEPTH Health venture capital transaction
Next: 5/1/2026: Ecodetect venture capital transaction
Share this article
About Database of VC Transactions
We report on funding rounds that are announced publicly. VC investment data records on this site are sourced from company press releases and news coverage. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs